Do Cytotoxic Chemotherapy Drugs Discharged into Rivers Pose a Risk to the Environment and Human Health? An Overview and UK Case Study

Research output: Journal contributionsJournal articlesResearchpeer-review

Standard

Do Cytotoxic Chemotherapy Drugs Discharged into Rivers Pose a Risk to the Environment and Human Health? An Overview and UK Case Study. / Johnson, Andrew C.; Jürgens, Monika D.; Williams, Richard J. et al.
In: Journal of Hydrology, Vol. 348, No. 1-2, 01.01.2008, p. 167-175.

Research output: Journal contributionsJournal articlesResearchpeer-review

Harvard

APA

Vancouver

Johnson AC, Jürgens MD, Williams RJ, Kümmerer K, Kortenkamp A, Sumpter JP. Do Cytotoxic Chemotherapy Drugs Discharged into Rivers Pose a Risk to the Environment and Human Health? An Overview and UK Case Study. Journal of Hydrology. 2008 Jan 1;348(1-2):167-175. doi: 10.1016/j.jhydrol.2007.09.054

Bibtex

@article{6732306ddb1546208d9914e678356edc,
title = "Do Cytotoxic Chemotherapy Drugs Discharged into Rivers Pose a Risk to the Environment and Human Health?: An Overview and UK Case Study",
abstract = "This opinion paper assesses for the UK, whether the current use of cytotoxic drugs, one of the most toxic pharmaceuticals in common use, could pose a risk to aquatic organisms and to humans through water recycling. A water quality model was set up for one of these drugs, 5-fluorouracil, in the Aire and Calder catchment in Northern UK. The study predicts 5-50 ng/L concentrations for long stretches of this catchment under low flow conditions. Due to their mode of action, practically all eukaryotic organisms are vulnerable to damage, with teratogenicity being the greatest concern at such levels. However, it is unclear to what extent the predicted low concentrations would affect flora and fauna in receiving waters but there may be an additive effect of a mixture of cytotoxic drugs which should be taken into account. The exposure of the pregnant mother, or more specifically her foetus, to these drugs via drinking water should be minimised. Current drinking water purification technology gives grounds for optimism on removal of these compounds, but no appropriate data exist yet. {\textcopyright} 2007 Elsevier B.V. All rights reserved.",
keywords = "cytotoxic, 5-Fluorouracil, CYCLOPHOSPHAMIDE, RISK ASSESSMENT, rivers, FISH, Chemistry",
author = "Johnson, {Andrew C.} and J{\"u}rgens, {Monika D.} and Williams, {Richard J.} and Klaus K{\"u}mmerer and Andreas Kortenkamp and Sumpter, {John P.}",
year = "2008",
month = jan,
day = "1",
doi = "10.1016/j.jhydrol.2007.09.054",
language = "English",
volume = "348",
pages = "167--175",
journal = "Journal of Hydrology",
issn = "0022-1694",
publisher = "Elsevier Publishing",
number = "1-2",

}

RIS

TY - JOUR

T1 - Do Cytotoxic Chemotherapy Drugs Discharged into Rivers Pose a Risk to the Environment and Human Health?

T2 - An Overview and UK Case Study

AU - Johnson, Andrew C.

AU - Jürgens, Monika D.

AU - Williams, Richard J.

AU - Kümmerer, Klaus

AU - Kortenkamp, Andreas

AU - Sumpter, John P.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - This opinion paper assesses for the UK, whether the current use of cytotoxic drugs, one of the most toxic pharmaceuticals in common use, could pose a risk to aquatic organisms and to humans through water recycling. A water quality model was set up for one of these drugs, 5-fluorouracil, in the Aire and Calder catchment in Northern UK. The study predicts 5-50 ng/L concentrations for long stretches of this catchment under low flow conditions. Due to their mode of action, practically all eukaryotic organisms are vulnerable to damage, with teratogenicity being the greatest concern at such levels. However, it is unclear to what extent the predicted low concentrations would affect flora and fauna in receiving waters but there may be an additive effect of a mixture of cytotoxic drugs which should be taken into account. The exposure of the pregnant mother, or more specifically her foetus, to these drugs via drinking water should be minimised. Current drinking water purification technology gives grounds for optimism on removal of these compounds, but no appropriate data exist yet. © 2007 Elsevier B.V. All rights reserved.

AB - This opinion paper assesses for the UK, whether the current use of cytotoxic drugs, one of the most toxic pharmaceuticals in common use, could pose a risk to aquatic organisms and to humans through water recycling. A water quality model was set up for one of these drugs, 5-fluorouracil, in the Aire and Calder catchment in Northern UK. The study predicts 5-50 ng/L concentrations for long stretches of this catchment under low flow conditions. Due to their mode of action, practically all eukaryotic organisms are vulnerable to damage, with teratogenicity being the greatest concern at such levels. However, it is unclear to what extent the predicted low concentrations would affect flora and fauna in receiving waters but there may be an additive effect of a mixture of cytotoxic drugs which should be taken into account. The exposure of the pregnant mother, or more specifically her foetus, to these drugs via drinking water should be minimised. Current drinking water purification technology gives grounds for optimism on removal of these compounds, but no appropriate data exist yet. © 2007 Elsevier B.V. All rights reserved.

KW - cytotoxic

KW - 5-Fluorouracil

KW - CYCLOPHOSPHAMIDE

KW - RISK ASSESSMENT

KW - rivers

KW - FISH

KW - Chemistry

UR - http://www.scopus.com/inward/record.url?scp=41649095306&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/8e672b5e-ef88-30ca-a301-3f2ee4bb34bb/

U2 - 10.1016/j.jhydrol.2007.09.054

DO - 10.1016/j.jhydrol.2007.09.054

M3 - Journal articles

VL - 348

SP - 167

EP - 175

JO - Journal of Hydrology

JF - Journal of Hydrology

SN - 0022-1694

IS - 1-2

ER -